Back to search

Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians

Data up to Jan 2025

Published2000
Citations81
References25

Total Citations Per Year

Abstract

References (25)

DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION

1996 • 764 citations

A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression

1993 • 267 citations

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study

1994 • 230 citations

Treatments of Psychiatric Disorders

1996 • 214 citations

Paroxetine and pindolol

1997 • 164 citations

Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy

1997 • 161 citations

Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.

1996 • 134 citations

Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.

1993 • 132 citations

An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.

1993 • 111 citations

What constitutes an adequate antidepressant trial for fluoxetine?

1990 • 106 citations

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol

1997 • 102 citations

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1996 • 99 citations

(−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

1996 • 77 citations

Combined treatment strategies in psychiatry.

1993 • 50 citations

Continuation and Maintenance Treatments of Major Depressive Disorder

1994 • 48 citations

Lithium augmentation in sertraline‐resistant depression: a preliminary dose‐response study

1993 • 42 citations

Dr. Stoll and Colleagues Reply

1996 • 38 citations

Comparison of two dosage regimens of fluoxetine in major depression.

1985 • 34 citations

Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression.

1997 • 34 citations

An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.

1996 • 33 citations

Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists

1997 • 33 citations

Psychiatrists' responses to failure of maintenance therapy with antidepressants

1997 • 30 citations

A Review of the Use of Augmentation Therapy for the Treatment of Resistant Depression: Implications for the Clinician

1997 • 20 citations

Strategies for Augmentation of SSRI Treatment: A Survey of an Academic Psychopharmacology Practice

1999 • 18 citations

329. Seizures associated with bupropion and SSRI co-therapy

1998 • 8 citations

Cited By (0)

Loading...